000 | 01993 a2200553 4500 | ||
---|---|---|---|
005 | 20250513121718.0 | ||
264 | 0 | _c19970721 | |
008 | 199707s 0 0 eng d | ||
022 | _a0300-9475 | ||
024 | 7 |
_a10.1046/j.1365-3083.1997.d01-437.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aUnger, M L | |
245 | 0 | 0 |
_aHigh dose IL-2-activated murine natural killer (A-NK) cells accumulate glycogen and granules, lose cytotoxicity, and alter target cell interaction in vitro. _h[electronic resource] |
260 |
_bScandinavian journal of immunology _cJun 1997 |
||
300 |
_a623-36 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCell Adhesion |
650 | 0 | 4 |
_aCell Communication _xdrug effects |
650 | 0 | 4 | _aCell Compartmentation |
650 | 0 | 4 |
_aCell Division _ximmunology |
650 | 0 | 4 |
_aCell Nucleus _xultrastructure |
650 | 0 | 4 |
_aCytoplasmic Granules _ximmunology |
650 | 0 | 4 |
_aCytotoxicity, Immunologic _xdrug effects |
650 | 0 | 4 | _aDose-Response Relationship, Immunologic |
650 | 0 | 4 |
_aGlycogen _xbiosynthesis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunophenotyping |
650 | 0 | 4 |
_aInclusion Bodies _xultrastructure |
650 | 0 | 4 |
_aInterleukin-2 _xpharmacology |
650 | 0 | 4 |
_aKiller Cells, Lymphokine-Activated _ximmunology |
650 | 0 | 4 | _aLipid Metabolism |
650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
650 | 0 | 4 | _aLymphoma |
650 | 0 | 4 |
_aLysosomes _xultrastructure |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMelanoma, Experimental |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aProteoglycans _xmetabolism |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTumor Cells, Cultured |
700 | 1 | _aHokland, M | |
700 | 1 | _aBasse, P H | |
700 | 1 | _aNannmark, U | |
700 | 1 | _aJohansson, B R | |
773 | 0 |
_tScandinavian journal of immunology _gvol. 45 _gno. 6 _gp. 623-36 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-3083.1997.d01-437.x _zAvailable from publisher's website |
999 |
_c9181815 _d9181815 |